Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PARSACLISIB Cause Electrocardiogram qt prolonged? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Electrocardiogram qt prolonged have been filed in association with PARSACLISIB. This represents 6.8% of all adverse event reports for PARSACLISIB.

5
Reports of Electrocardiogram qt prolonged with PARSACLISIB
6.8%
of all PARSACLISIB reports
0
Deaths
5
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From PARSACLISIB?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PARSACLISIB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does PARSACLISIB Cause?

Off label use (23) Disease progression (15) Pyrexia (14) Pneumonia (11) Bronchitis (9) Neutropenic sepsis (9) Neutrophil count decreased (9) Blood lactate dehydrogenase increased (8) Neutropenia (8) Hypokalaemia (7)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Related Pages

PARSACLISIB Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged PARSACLISIB Demographics